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Salivary  gland  hypofunction,  also  termed  as  xerostomia,  is  caused  by  radiation  therapy  for  head  and
neck cancer  or Sjögren’s  syndrome,  leading  to  a detrimental  impact  on oral  health  and  quality  of  life.  This
review  describes  current  studies  on  salivary  gland  development  and  the  translational  approaches  of basic
science  to treating  patients  with  dysfunction  and  hypofunction  of  the salivary  gland.  Here,  we review  the
most  recent  studies  that  have offered  better  insight  into  the  mechanisms  of salivary  gland  developmenteywords:
evelopment
egeneration
alivary gland
tem cells
and  regeneration.  Furthermore,  we  highlight  proposed  approaches  with  the  aim  of recovering  salivary
gland  function  using  both  gene-  and  cell-based  therapy.  A thorough  understanding  of  the mechanisms
involved  in  salivary  gland  development  is  necessary  in order  to design  effective  therapies  for  regeneration
and  repair  of  damaged  salivary  glands.
© 2015  Japanese  Stomatological  Society.  Published  by Elsevier  Ltd.  All  rights  reserved.
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. Introduction realize the regeneration of the tooth and bone. Since cultured epi-Many papers have reported the potential of regenerative
edicine. However, many scientiﬁc challenges need to be over-
ome. In particular, many clinicians in the ﬁeld of dentistry hope to
∗ Tel.: +81 6 6879 2275; fax: +81 6 6879 2279.
E-mail address: sakai@dent.osaka-u.ac.jp
ttp://dx.doi.org/10.1016/S1348-8643(15)00040-3
348-8643/© 2015 Japanese Stomatological Society. Published by Elsevier Ltd. All rights rdermal skin was  developed using tissue engineering [1], cultured
dermis has also been developed and recently made available to clin-
ics worldwide. The epithelial cells of the oral membrane are similar
to skin keratinocytes. Bioengineered oral mucosae have also been
developed as well as bioengineered skin. Various reports regarding
the development and clinical implementation of bioengineered
oral mucosa sheets have been published since 1990. Bioengineered
oral mucosa sheets are expected to be a useful tool for clinical
eserved.
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pplication, among others. Recently, tissue engineering therapy has
een used to regenerate tissues such as alveolar bone, local carti-
age, skin epidermis, corneal epithelium, and pancreatic islets. As
etal bovine serum and mouse-originated feeder cells are required
or these culture methods, risk factors with respect to mad  cow
isease and/or unknown pathogens are present. To avoid these
roblems, a new strategy that does not involve fetal bovine serum
nd mouse-originated feeder cells needs to be developed.
Induced pluripotent stem (iPS) cells can be generated from fully
ifferentiated non-pluripotent cells with similar pluripotency to
hat of embryonic stem (ES) cells. iPS cells can be a powerful
ool in regenerative medicine. Many researchers have attempted
o regenerate organs, such as salivary glands, kidneys, and lungs.
owever, their potential tumorigenicity poses a signiﬁcant chal-
enge to clinical use [2,3]. Conversely, ES cells and other stem cells
ave a self-renewing microenvironment and multi-lineage devel-
pmental potential. Recent studies have shown the potential of
icroenvironments to exert external control, which is involved in
eﬁning the stem cell niche. The stem cell niche may  represent
 signiﬁcant entry point for the therapeutic modulation of stem
ell behavior [4]. Although the microenvironment is known to be
erived from iPS cells, the niche of iPS cells has not been stud-
ed in depth [3]. In this review, the mechanisms of development
nd regeneration approaches using the salivary gland are described.
hese analyses may  provide new concepts for the functional regen-
ration of salivary glands using tissue engineering.
. Structure and function of salivary gland
Humans and mice have three major salivary glands: sub-
andibular glands, the parotid glands, and the sublingual glands,
hich are responsible for secreting approximately 90% of the saliva
n the mouth [5]. In addition, hundreds of minor salivary glands
re present under the mucosa in the oral cavity, which secrete
he remaining 10% of the saliva together. Salivary glands produce
aliva and play an important role in the homeostasis of the oral
avity such as food digestion, taste, moisturizing, and immunore-
ction. Acinar cells of the salivary glands secrete the serous ﬂuid and
ucus of saliva, which contain water, salt, and protein, among oth-
rs. However, duct cells absorb salt and adjust to salivary secretion
ccordingly. Myoepithelial cells surround the acini-interposed sec-
ion; these cells are controlled by the nerve that regulates salivation
y contraction. However, this phenomenon has not yet been clearly
emonstrated. Salivary glands contain three types of ducts based
n their morphology and histological shape: intercalated, striated,
nd granular. Saliva ﬂows from the acinar units through the ductal
ystem into the oral cavity.
. Early development of salivary gland
The signals that induce the migrating neural crest cells to form a
esenchymal condensation at the appropriate location beside the
ral epithelium are still unclear. The mesenchyme provides sig-
als for the thickening of the oral epithelium and the formation
f placodes at embryonic day 11 (E11). Knockout mice for Fgf10,
gfr2b, Pitx1, and p63 lack salivary glands, indicating that these
enes are essential for the early development and patterning of sali-
ary glands. In organs such as the liver and pancreas, the endothelial
ells provide critical signals for organogenesis [6]. However, the
ole of endothelial cells in early salivary gland development has
ot been investigated yet. The salivary placode invaginates into the
esenchyme, which begins to condense. The epithelial bud grows
nto the mesenchyme forming a primary bud on a stalk. The neural
rest-derived neuronal precursors coalesce to form the parasym-
athetic submandibular ganglion (PSG), which is wrapped aroundtional 13 (2016) 7–14
the epithelial stalk that subsequently forms the major secre-
tory duct. The signals that initiate this interaction have not been
deﬁned [7].
4. Branching morphogenesis
Salivary glands are formed by the developmental process of
branching morphogenesis, which involves cell proliferation, cleft
formation, differentiation, cell migration, apoptosis, and recipro-
cal interaction between the epithelial, mesenchymal, neuronal, and
endothelial cells [8]. As the end bud enlarges at E13, clefts in the
epithelium delineate the ﬁrst three to ﬁve buds, which correspond
to major lobules of the gland; in parallel, axons from the PSG extend
along the epithelium to envelop the end buds. The gland becomes
highly branched by E14 and begins differentiating functionally at
E15. Branching morphogenesis and differentiation continue until
birth [9,10]. We  review speciﬁc mechanisms involved in branching
morphogenesis in the following sections.
4.1. Cleft formation
Cleft formation is an essential process that occurs due to two
separate phenomena: cleft initiation and progression. Basement
membrane (BM) dynamics are the possible driving forces for cleft
formation. Fibronectin is essential for cleft initiation [8], and its
accumulation rapidly induces the expression of Btbd7 (BTB (POZ)
domain containing 7), which induces the expression of Snail2 and
suppresses the level of E-cadherin, a cell–cell adhesion molecule
[11]. This results in a loss of the columnar cell organization in the
outer layer of the epithelial cells at the base of the forming cleft,
as well as the formation of intercellular gaps for cleft progression.
Other extracellular matrix (ECM) proteins in the BM accumulate at
the cleft sites including the laminin chains 1 and 5 [12], perlecan,
and heparanase, an endoglycosidase enzyme that cleaves heparan
sulfate chains [13]. Submandibular glands (SMGs) in laminin 5
(Lam5)-deﬁcient mice showed delayed branching morphogenesis
with delayed cleft formation. The loss of GSK3 by either phar-
macological inhibition or transcriptional repression promotes cleft
formation [14]. Electron microscopy analysis clearly indicated the
cytoskeletal dynamics of cleft formation. Ultrastructural images
showed the presence of a cytoplasmic shelf with a core of micro-
ﬁlaments in tissues at the base of the cleft [15]. The shelf may  be a
matrix attachment point to induce cleft elongation via cytoskeleton
attachment, and inhibition of the actin cytoskeleton polymeriza-
tion in turn inhibits cleft formation. Another study showed that
cleft initiation and progression are physically and biochemically
distinct. Rho-associated coiled-coil containing kinase (ROCK) bio-
chemically regulates the transition of initiated clefts to undergo
cleft progression [16].
4.2. Proliferation
Cleft formation is coordinated with cell proliferation during
branching morphogenesis with the increase in the size of the
epithelium. Rapid proliferation of the developing SMG  is mainly
localized at the peripheral end buds, suggesting the presence of pro-
liferating progenitor cells. Fibroblast growth factor (FGF) signaling
is essential for the proliferation and survival of salivary gland pro-
genitors. Fgfr2b−/− and Fgf10−/− mice have no salivary glands,
although epithelial buds are formed but degenerate by E12.5 [17].
Both exogenous FGF10 and FGF7 bind to Fgfr2b and increase the
epithelial proliferation of SMG; however, FGF7 induces budding
whereas FGF10 induces duct elongation [18]. These differences are
probably due to the binding afﬁnities of the FGFs to heparan sulfate
as well as the endocytic recycling of the FGFR.
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In addition, platelet-derived growth factor (PDGF) signaling reg-
lates FGF signaling. FGFs 1, 3, 7, and 10, which are produced by
he mesenchyme, function downstream of PDGF signaling. Exoge-
ous PDGF induces FGF expression and increases the proliferation
f the epithelium, whereas loss of PDGF via short interfering RNA
siRNA) knockdown inhibits FGF expression [19]. Furthermore, an
MG branching defect caused by the functional inhibition of PDGF
an be rescued by exogenous FGF7 and FGF10, consistent with FGF
eing downstream of PDGF signaling.
Epidermal growth factors (EGFs) and their receptors are crucial
or the proliferation of SMGs. The SMGs of EGFR-null mice show
educed proliferation, branching morphogenesis, and maturation
f the epithelium [20]. Function-blocking antibodies to neuregulin
 (Nrg1) inhibit ex vivo SMG  branching morphogenesis, whereas
xogenous Nrg1 increases branching morphogenesis [21]. Acetyl-
holine (Ach)/muscarinic (M)  receptor 1 signaling increases EGFR
rotein expression in the SMG, and HB-EGF increases proliferation
f keratin 5 (K5)-positive progenitors in an EGF-dependent manner
22].
Wnt  signaling has many biological functions including prolifer-
tion, differentiation, organogenesis, and cell migration [23]. Wnt
ignaling is highly dynamic during SMG  development. It is localized
n the mesenchyme in the early stages, but it is localized to the duc-
al epithelium after E14.5 [24,25]. A reduction in Wnt  signaling with
hemical inhibitors or conditional knockout of -catenin in the
MG  mesenchyme reduced epithelial branching [25]. Wnt  signaling
n the end buds is repressed by FGF signals through induction
f the Wnt  antagonist secreted frizzled-related protein 1 (sFRP).
his inhibitory effect maintains the end buds in an undifferenti-
ted state while the ductal structures continue to differentiate [24].
ther studies have shown that postnatal Wnt  activity is detected
n the intercalated ducts of SMGs, the putative stem cell compart-
ent [26]. Activation of Wnt/-catenin signaling speciﬁcally in the
dult K5+ progenitors promoted ductal proliferation and progeni-
or expansion.
.3. Cell migration and cell–cell/cell–ECM adhesions
Time-lapse analyses of ﬂuorescently labeled epithelia during the
arly stages of SMG  development have shown a high motility of
pithelia in individual cells or clusters of cells [27]. Cell migra-
ion is dynamic, and both outer columnar cells and the central
ore of polymorphic cells move randomly, although the outer cells
igrated farther [15]. Similarly, tracking studies using a combina-
ion of photo-conversion of KikGR (Kikume green–red) show that
ell motility is highest in cells in contact with the BM.  This motility
s integrin and myosin-II dependent but not E-cadherin dependent.
y contrast, the motility of cells within the end bud is restrained
y E-cadherin [28]. Thus, region-speciﬁc differences in cell–matrix
nteractions and cell motility within the epithelial end buds con-
ribute to different processes during branching morphogenesis.
adherins are cell–cell receptors, and two cell populations exist
ith distinct E-cadherin junctional organization and developmen-
al outcome during SMG  development. The outer peripheral cells,
hich contain well-organized junctions and express a neonatal aci-
ar differentiation marker, are committed to the acinar lineage
s early as E13.5. By contrast, the cells in the inner buds with
ess-deﬁned junctions express duct-speciﬁc markers such as K7
nd form ductal structures [29]. Once ductal lumens are formed,
he junctions of E-cadherin stabilize the ductal structures. Func-
ional inhibition of E-cadherin only affects the organization of inner
ud cells and causes cell death, indicating that these E-cadherin
unctions provide a survival signal to the maturing duct cells.
urthermore, expanded lumens are formed in the SMG  of p120-
eﬁcient mice, which is a stable partner of E-cadherin [30].tional 13 (2016) 7–14 9
Integrins are heterodimeric receptors that bind ECM proteins
in the BM.  The SMGs of integrin Itg3−/− embryo have defec-
tive apical–basal cell polarity and altered expression patterns of
E-cadherin, 5 integrin, and ﬁbronectin [31]. SMGs that use siRNA
knockdown of ﬁbronectin show a decrease in cleft formation and
branching morphogenesis, and the ﬁbronectin protein rescues
defective branching morphogenesis [8]. Severe SMG  phenotypes
occur in Itg3−/−:Itg6−/− double-knockout mice, showing a
delay in epithelial branching and disorganization of the epithelial
cells [12]. Lam5-knockout mice have a similar SMG  phenotype to
Itg3−/−:Itg6−/− mice. Further studies using siRNA knockdown
of Lam5 show a decrease in branching morphogenesis, mitogen-
activated protein kinase (MAPK) phosphorylation, and FGFR gene
expression. Addition of exogenous FGF10 rescues branching mor-
phogenesis in Lam5 siRNA-treated SMGs; in turn, FGFR siRNA
decreases Lam5, suggesting a reciprocal regulation of laminin
and FGF signaling. These studies reveal the dynamic role of ECM
receptors and FGF signaling in SMG  development.
5. Progenitor cells
It is clear that multiple progenitor populations are present in
both embryonic and adult salivary glands. Many nuclear, cytoplas-
mic, and cell surface markers have been used to characterize the
progenitor cells of the salivary glands. In murine models, progenitor
cells expressing Kit are capable of regenerating damaged SMGs [32].
In both human and mouse adult SMGs, Kit+ cells are localized in
the intercalated and excretory ducts. In the developing embryonic
SMG, Kit is localized in the peripheral epithelial end bud cells, and
Kit signaling maintains and expands the Kit+, keratin 14 (K14)+ dis-
tal progenitors in concert with FGFR2b signaling [33]. Furthermore,
epithelial Kit+, K14+ cells direct ductal morphogenesis by commu-
nicating with the surrounding neuronal niche and proximal K5+
epithelial progenitors. This occurs because Kit+ cells produce neur-
turin (NRTN), which promotes parasympathetic nerve survival and
axon extension. This in turn maintains the K5+ progenitors and, in
concert with EGFR signaling, promotes their ductal differentiation.
Recent research has shown that K5+ cells are progenitor popula-
tions in the SMG, and K5-expressing cells are mainly localized in
the ducts. K14+ cells give rise to various cell types in the epithelial
compartment including acini, myoepithelial cells, and ducts, as well
as K5-expressing cells. This may  suggest that K14+ cells constitute
a multipotent epithelial progenitor population in the SMG.
Sox2 is important for the maintenance of pluripotent stem cells
and for the formation of various tissues in the development process.
Sox2 cells are putative stem/progenitor cells in the adult sublin-
gual gland [34]. Sox2 is expressed during embryonic development
within the K5 population, ∼17% of which express Sox2 [35]. Further
experiments are needed to determine whether Sox2+ cells in adult
SMGs are stem cells.
Adult progenitor cells expressing the Ascl3 transcription factor
are present in the ducts of mouse salivary glands [36]. Development
of small salivary glands containing K5+ basal cells was  observed
in Ascl3−/− mice, which may  indicate that adult salivary glands
contain more than one population of progenitor cells and can com-
pensate for the loss of Ascl3+ progenitor cells. Ascl3+ salispheres
generate multiple salivary cell types in culture over time but were
not K5+. It indicates that K5 may  be an independent population.
Salivary gland progenitor cells expressing 6 integrin (CD49f)
and intracellular laminin can be isolated following duct ligation;
these cells are able to differentiate into hepatic, pancreatic, or
salivary gland-like cells [37]. Similar kinds of cells were isolated
using heat stress-conditioned rats, in which the number of 61-
expressing cells as well as their proliferation and clonal capability
increased [38].
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. Clinical approaches to restore the function salivary gland
Radiation therapy, surgery, and chemotherapy are the common
reatment methods for head and neck cancer (HNC). Therefore, sali-
ary glands are frequently exposed to radiation. Due to the high
adiosensitivity of salivary glands, irreversible dysfunction of sali-
ation occurs in 60–90% of cases. In addition to affecting one’s taste,
educed salivary secretion leads to dental caries; periodontal dis-
ase; and chewing, swallowing, and language disorders. All of these
onditions impair the patients’ quality of life. Understanding the
echanism of salivary gland development could provide a model
or gland regeneration as well as tissue engineering approaches
o create an artiﬁcial gland. Several strategies have been proposed.
ere, we review gene therapy, cell-based therapies, and tissue engi-
eering approaches to produce an artiﬁcial gland.
.1. Regeneration using gene therapy
Gene therapy involves transferring a gene into cells to alle-
iate various diseases and cellular dysfunctions. A Phase I gene
herapy clinical trial in patients with radiation-induced salivary
ypofunction recently provided effective results [39]. In this study,
he aquaporin (Aqp1) gene was transferred to parotid glands via
etroductal cannulation. In addition, human KGF (FGF7) gene ther-
py using a hybrid serotype5 adenovirus vector in murine SMGs
revented radiation-induced salivary dysfunction [40]. Acinar cell
roliferation, the number of endothelial cells, and saliva ﬂow were
ound to increase.
The Wnt/-catenin pathway is known to control the
tem/progenitor cells in the SMG. Wnt/-catenin signaling is
ctivated after ligation–deligation of the main excretory duct, and
ts forced activation in the basal epithelia expands stem/progenitor
ells [26]. Interestingly, damage as a result of radiation therapy
oes not activate the signaling pathway. However, transient
ctivation of the Wnt/-catenin pathway in male mice prevents
oth acute and chronic hyposalivation by inhibiting apoptosis and
reserving the stem/progenitor pool [41]. Further study is needed
o decide speciﬁc targets that can be used either for gene therapy
r as effective targets.
The neurotrophic factor NRTN can also be used to protect
eurons from damage due to apoptosis of acinar tissue and loss
f endogenous NRTN in gene therapy. Radiation therapy causes
poptosis of epithelial cells within 1 day, and a reduction in
arasympathetic innervation 3 days later due to subsequent neu-
onal apoptosis [7]. Addition of exogenous NRTN to irradiated
etal SMGs reduces neuronal apoptosis and restores parasym-
athetic function, which in turn promotes the regeneration of
he epithelium. Similarly, in human SMGs, irradiation reduces
arasympathetic innervation [7]. Gene therapy with NTRN may
rotect SMGs from radiation.
.2. Activation/silencing of gene
The activation of genes has been studied for inducing the regen-
ration of salivary glands after irradiation. Treating mice with
lda-89, a selective aldehyde dehydrogenase 3 (ALDH3) activator,
nriches Kit+/CD90+ progenitors and increases the proliferation
f salispheres [42]. These salivary gland progenitor cells express
igher levels of Aldh3 than non-progenitor cells do. Injection
f Alda-89 may  induce saliva secretion after radiation therapy,
lthough optimization of drug dose and treatment duration is nec-
ssary. Approaches to gene silencing include microRNA (miRNA)
r naked RNA treatment, which selectively target a single gene
r pathway. A retroductal injection of siRNA-coated nanoparticles
nto mouse salivary gland has proven to be effective in protec-
ing from radiation. siRNAs targeting a proapoptotic Pkc genetional 13 (2016) 7–14
administered prior to radiation therapy prevented apoptosis and
improved saliva secretion in irradiated animals [43].
6.3. Regeneration using cell therapy
One form of cell therapy is to isolate autologous progenitors
from the patient’s biopsy sample before radiation, to grow and cry-
opreserve these cells during radiation, and then to implant them
into the irradiated gland [32]. Cell-based therapy using human
adipose-derived mesenchymal stem cells (hAdMSCs) has been
reported to repair or restore salivary gland tissues damaged by
irradiation. This process involved repeated injection of hAdM-
SCs (1 × 106) into the tail veins of mice immediately following
local irradiation. The salivary ﬂow rates (SFRS) and salivation lag
times were then monitored to functionally evaluate the success
of the treatment at 12 weeks. The hAdMSC-transplanted sali-
vary glands exhibited fewer damaged and atrophied acinar cells
and higher levels of mucin and amylase than the irradiated sali-
vary glands left untreated. The transdifferentiation of hAdMSCs
into amylase-producing salivary gland epithelial cells was then
histopathologically observed in vitro using a coculture system. This
result indicates the potential of hAdMSCs to confer protection from
irradiation-induced cell loss and to transdifferentiate into salivary
gland epithelial cells [44].
Dissociated salivary gland epithelial cells self-organize and
undergo branching morphogenesis to form tissues with structural
features (Fig. 1) and differentiation markers characteristic of the
intact gland [45]. Alternatively, a gland bioengineered in vitro may
be implanted into the salivary gland space to restore gland func-
tion. A recent study showed that a bioengineered gland made
from the fetal epithelium and mesenchyme can be transplanted
into an adult mouse to form a new functional gland in the adult
microenvironment [46]. This bioengineered gland contained a vari-
ety of fetal cells, including progenitors of epithelial, mesenchymal,
endothelial, and neuronal cells. Interestingly, the salivary gland
reconnected with the ductal system, thus restoring secretion of
saliva to protect the oral cavity from bacteria as well as the function
of swallowing. A future goal would be to use iPS cells or adult sali-
vary progenitor cells to form a bioengineered rudiment that grows
into a conventional gland in the adult animal.
Transplantation of iPS cells into submandibular glands in severe
combined immunodeﬁciency (SCID) mice led to the formation
of teratomas, showing ES cell-like derivation of cells and tissues
representative of all three germ layers including the endoderm,
mesoderm, and ectoderm (Fig. 2). However, there is a risk of
tumorigenesis in the iPS cells after transplantation. To avoid tumor
formation, cell sorting using a speciﬁc molecular marker is nec-
essary to eliminate all cells except for the differentiated cells of
the target organ. However, treatment methods using this approach
are expensive. To elucidate the mechanism of iPS-induced differ-
entiation, a coculture of embryonic salivary gland cells with iPS
cells was investigated (Fig. 3) [3]. iPS cells cannot mix  completely
with salivary gland cells. The number of acinar-like structures in
regenerated salivary glands was increased by iPS cells. The size
of acinar-like structures was decreased by iPS cells (Fig. 4). These
phenomena indicated that iPS cells differentiate embryonic regen-
erated salivary gland tissues. The hardness of the environment and
the expression of hormones in the environment are essential to
controlling the size of organs and overgrowth [47]. Cell adhesion
and FGF signaling in salivary glands were investigated [48]. iPS
cells may  undergo branching morphogenesis to form tissues with
structural features and differentiation markers characteristic of the
intact gland.
The spheroid culture of adult salivary gland cells has been used
to identify adult progenitors for cell therapy. This salisphere cul-
ture enriches progenitors expressing Kit, Sca-1, and Musashi-1 [32].
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Fig. 1. Phase-contrast image of regenerated SMG in organ culture for 96 h. The regenerated SMG  contained many acinar-like structures. Scale bars, 0.5 mm.  The boxed area
of  the image was  enlarged from the left picture to the right picture. Immunoﬂuorescence of sections showed acinar-like structures. E-cadherin, GFP, Nuclear, and Merged.
Scale  bars, 25 m.
Fig. 2. Histopathological features of teratoma formation after transplantation of iPS cells into the salivary glands of SCID mice. Transplantation of 5.0% × 105 iPS cells formed
a  teratoma. H&E-stained sections of a teratoma showed derivatives of all three germ layers, including gut-like epithelium tissues (endoderm), adipose tissues and muscles
(mesoderm), and neural tissues and keratin-containing epidermal tissues (ectoderm). Scale bars, 50 m.
12 T. Sakai / Oral Science International 13 (2016) 7–14
Fig. 3. Aggregation of dissociated SMG  cells in iSG. SMG  cells and GFP–iPS cells were cocu
Phase-contrast image and immunologically stained image showed GFP–iPS, E-cadherin, P
Fig. 4. Effect of iPS cells on aggregation of dissociated SMG  cells. iPS cells cannot
mix  completely with dissociated SMG  cells, instead surrounding the epithelium of
SMG. SG consists of 100% SMG  cells, and iSG consists of 20% iPS cells and 80% SMG
cells. iPS cells reduced the size of the salivary epithelial tissue, that is, acinar-like
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Salivary gland development involves the interaction of varioustructures, in the regenerated salivary gland but increased their number.
ntraglandular transplantation of 300 Kit+ cells isolated from sal-
spheres into irradiated recipient mouse SMGs restored the gland
orphology and partly restored function. In serial transplantation
xperiments, only 100 Kit+ cells were required for a secondary
ransplant [32]. Salisphere-derived cells that expressed Kit with
D24 and CD49f also improved saliva production [49,50]. After
ransplantation, an increase in ductal cells and stem cells, normal-
zation of the vasculature, and decrease in ﬁbrosis were induced
50].
Various approaches to using bone marrow-derived stem cells
o regenerate SMGs [51] or even a lysate of these cells [52] are
vailable, although the mechanism of regeneration has not yet
een elucidated. In addition, the intraglandular transplantation of
one marrow mesenchymal stem cells improves saliva production,
educes apoptosis, and increases microvessel density in irradiated
ice. Transdifferentiation into acinar cells following transplanta-
ion has been observed [53].
Recently, a personal stem cell bank was developed, wherein
alivary gland integrin 61+ cells were cryopreserved for up to
 years without any effect on their genetic or functional stability
54]. Furthermore, methods to enrich sufﬁcient numbers of adult
alivary stem cells for therapy are needed. Salivary progenitors canltured with DMEM/F12 for 96 h. iSG is composed of 20% iPS cells and 80% SMG cells.
CM, and merged image. Scale bars, 25 m.
be induced in culture to express pancreatic markers, thus serving
as a potential source of cells for gland hypofunction and diabetes.
6.4. Tissue engineering approaches
The regeneration of salivary glands using tissue engineering
requires cells that express salivary gland-speciﬁc biomarkers and
a biocompatible scaffold that recreates the microenvironment of
the salivary gland. In vitro regeneration of lung tissue in rats was
attempted by removing cellular components while leaving behind
a scaffolding of extracellular matrices, which retained the hierar-
chical branching structures of the airways and vasculature. With
the help of a bioreactor, the pulmonary epithelium and vascular
endothelium were cultured on the acellular lung matrix. Remark-
able hierarchical organization appeared within the endothelial
cell-seeded matrix, which efﬁciently repopulated the vascular
compartment over time. The mechanical characteristics of the in
vitro-engineered lungs seemed to be comparable to those of native
lung tissue. When implanted in vivo into rats for time periods
ranging from 45 to 120 min, the engineered lungs were found to
participate in gas exchange. Although the ultimate goal of generat-
ing fully functional lungs in vitro has yet to be achieved, these initial
results support the viability of lung regeneration via repopulation
of the lung matrix [55,56].
One strategy is to produce an artiﬁcial gland by seeding cells
on a three-dimensional (3D) scaffold to create an in vivo gland
microenvironment. Hyaluronic acid (HA) hydrogels support pri-
mary human salivary gland cells, which form spheroid structures.
These cells proliferate to create large acini-like structures, which
can be maintained for a prolonged duration in vitro. The structures
signal in response to neurotransmitters and continue to secrete
amylase when implanted in vivo into rats [57,58]. When used
as a scaffold, polylactic–glycolic acid (PLGA) induces the attach-
ment, proliferation, and survival of salivary gland epithelial cells
[59]. Nanoﬁber PLGA scaffolds additionally support the branching
of embryonic SMGs and self-organization of dissociated primary
gland cells into branched, gland-like structures. Lithographically
micropatterning curved “craters” that mimic  the physical struc-
ture of the BM increased the surface area and allowed apicobasal
polarization and acinar differentiation [60]. These studies are rep-
resentative of the pioneering work conducted in the ﬁeld of salivary
gland regeneration using tissue engineering.
7. Conclusioncells including epithelial cells, mesenchymal cells, endothelial cells,
and nerve cells. This review is not intended to be an exhaustive
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ist of all available studies, but it does include as many reviews
s possible of the most recent literature on the development and
egeneration of salivary glands. For example, the role of angiogen-
sis in the development process has not been analyzed yet. The
nteraction and mechanisms that control the differentiation of stem
ells/progenitor cells of the salivary glands have not yet been elu-
idated. In the future, our goal will be the establishment of a 3D
rtiﬁcial organ regeneration model. Further exploration of this ﬁeld
an add new insights into aspects of regeneration research.
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